AMD Announces 10 Billion Investment in Taiwans AI Chip Ecosystem AI Economy Reshapes American Dream BlueCollar Workers Emerge as Key Winners in ATTs Growth Strategy Xponential Fitness Names Danielle Porto Parra as President Bolstering Leadership Team T Rowe Price Group Named Among Top HighYield Stocks for Retirement Income Stellantis Turnaround Plan Prediction Market Regulation and Ouras IPO Filing Highlight Morning Market Movers SpaceX Files for IPO Under Ticker SPCX Could Boost Elon Musks Trillionaire Status STM Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher BMBL Q1 2026 Earnings EPS Beat Drives Slight Stock Uptick as User Trends Remain in Focus FCX Q1 2026 Earnings Strong Earnings Beat Amid Robust Copper Demand PTON Q1 2026 Earnings EPS Miss Masks Optimism Stock Surges 1023 USAC Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds PWP Q1 2026 Earnings EPS Misses Estimates by 6931 as Stock Declines Allspring Global Dividend Opportunity Fund EOD Edges Higher Amid Steady Momentum Vine Hill Capital Investment Corp II Units VHCPU Holds at 1002 as Trading Remains Quiet Alkermes ALKS Moves Higher on AboveAverage Volume Testing Key Resistance Zone BrandywineGLOBAL Global Income Opportunities Fund BWG Edges Higher as Income Demand Persists Cadrenal Therapeutics CVKD Slides 52 as Support Level Comes into Focus Microsofts Anthropic Partnership May Unlock 43 Billion Azure Revenue by 2030 HSBC Suggests Enbridge Inc ENB Q1 2026 Earnings Earnings Beat Expectations on Strong Operational Performance Shift4 Payments FOUR Slides Slightly as Traders Weigh Resistance Levels RYTHM Inc RYM Q3 2022 Earnings Deep EPS Miss Reflects Ongoing Operational Challenges AMT Q1 2026 Earnings Strong EPS Beat Driven by Portfolio Growth and Margin Expansion CMCT Q3 2024 Earnings Massive EPS Miss Sends Stock Lower Outlook Therapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Surges 29 INOD Q1 2026 Earnings Massive EPS Beat Drives Investor Skepticism Recursion Pharmaceuticals Q1 2026 Earnings EPS Beat Amidst Pipeline Development KURA Q1 2026 Earnings WiderthanExpected Loss Highlights ClinicalStage Biotechs Cash Burn